| Literature DB >> 9373656 |
P E Kofoed1, E Mapaba, F Lopes, F Pussick, P Aaby, L Rombo.
Abstract
For treatment of malaria, the World Health Organization recommends 10 mg of quinine per kg body-weight 3 times a day for at least 7 d. In Guinea-Bissau, as in several other African countries, a 3 d treatment regimen (10 mg/kg twice daily) is currently used. We therefore compared the 3 d treatment period with periods of 5 and 7 d. A total of 145 children with clinical malaria due to monoinfection with Plasmodium falciparum, with > or = 20 parasites per 200 leucocytes, were treated with intramuscular Quinimax 10 mg per kg body-weight twice daily for 3, 5 or 7 d. The children were then examined once weekly for 4 weeks. Following the 3 d treatment regimen, 34 of 43 children (79%) had parasitaemia on day 28 or before; following the 5 d treatment regimen, 36 of 40 children (90%) did so; and following the 7 d treatment regimen, 7 of 62 children (11%) were parasitaemic at that time. This study thus suggests that the currently recommended 3 d Quinimax treatment regimen in Guinea-Bissau for moderate and severe malaria is not effective.Entities:
Keywords: Africa; Africa South Of The Sahara; Age Factors; Child; Demographic Factors; Developing Countries; Diseases; Drugs--therapeutic use; Guinea-bissau; Malaria; Parasitic Diseases; Population; Population Characteristics; Population Dynamics; Portuguese Speaking Africa; Research Report; Time Factors; Treatment; Western Africa; Youth
Mesh:
Substances:
Year: 1997 PMID: 9373656 DOI: 10.1016/s0035-9203(97)90286-8
Source DB: PubMed Journal: Trans R Soc Trop Med Hyg ISSN: 0035-9203 Impact factor: 2.184